Skip to main content
Premium Trial:

Request an Annual Quote

So Many Preprints

The COVID-19 pandemic has boosted the use of preprint servers in the biological sciences, The Scientist writes.

It notes that the ArXiv preprint for physics has been around for decades, but that the life sciences have been slower to embrace preprint servers: BioRxiv was established in 2013 and MedRxiv even more recently in 2019. The Scientist writes that while preprints had been increasing in popularity, the pandemic and the need to quickly get information out has "accelerated their use." In particular, it says an estimated one-quarter of all COVID-19-related scientific articles from the first 10 months of the pandemic were preprints. The Economist reported in May 2020 that there had already been more than 2,850 articles about SARS-CoV-2 or COVID-19 posted to BioRxiv or MedRxiv at that time.

The quick and unvetted release of papers has raised concerns about spreading misinformation, The Scientist adds. But it notes that a recent analysis suggests that, for the preprints that are eventually published, there is often little difference between the preprint and final article and that a Retraction Watch tally indicates that of the 137 COVID-19–related articles removed by journals or servers, 22 were preprints.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.